Λίστα αντικειμένων
We discussed about preliminary analysis of the prospective, multicenter, phase III NEUTRODIET trial, which is studying the effects of diet on infection rates during neutropenia in patients undergoing autologous (auto)- or allogeneic (allo)‑HSCT. Data presented at EHA2022
Presenter: Prof. Spyridonidis
Participants: Dr. Liga, Dr. Tsokanas, Dr. Valera
Presenter: Prof. Spyridonidis
Participants: Dr. Liga, Dr. Tsokanas, Dr. Valera